Back to news archive
Image for New QuickMIC® study started in Europe
News 2023-10-02

New QuickMIC® study started in Europe

We are proud to announce the start of a new QuickMIC® study in Hungary.

The QuickMIC system will be evaluated at the Department of Medical Microbiology and Immunology at the University of Pécs, Hungary.

The laboratory is headed by Dr Agnés Pál-Sonnevend, MD, PhD, an Associate Professor at the University of Pécs, researching antimicrobial resistance. The study is in collaboration with our distributor Biomedica, which distributes the QuickMIC system in Austria, Switzerland and Central Eastern Europe.

“We are very excited about this study and the collaborative efforts to further confirm the superior performance of our QuickMIC system. It´s also a great pleasure to work with the highly experienced and professional team of Dr Pál-Sonnevend”, says Dr Anna Olsson, Clinical Study Manager at Gradientech.

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2023 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book